Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$241K Hold
2,000
0.09% 44
2025
Q4
$211K Buy
+2,000
New +$188K 0.07% 49
2024
Q4
Sell
-2,600
Closed -$297K 75
2024
Q3
$297K Hold
2,600
0.12% 49
2024
Q2
$322K Hold
2,600
0.14% 43
2024
Q1
$343K Hold
2,600
0.16% 43
2023
Q4
$283K Hold
2,600
0.15% 46
2023
Q3
$268K Hold
2,600
0.16% 42
2023
Q2
$300K Hold
2,600
0.18% 43
2023
Q1
$277K Hold
2,600
0.18% 47
2022
Q4
$288K Hold
2,600
0.21% 43
2022
Q3
$224K Hold
2,600
0.17% 40
2022
Q2
$237K Hold
2,600
0.16% 46
2022
Q1
$213K Buy
+2,600
New +$205K 0.11% 51
2021
Q3
Sell
-2,600
Closed -$202K 89
2021
Q2
$202K Sell
2,600
-125
-5% -$9.3K 0.08% 60
2021
Q1
$200K Hold
2,725
0.09% 63
2020
Q4
$213K Hold
2,725
0.09% 58
2020
Q3
$216K Hold
2,725
0.11% 56
2020
Q2
$201K Hold
2,725
0.11% 54
2020
Q1
$200K Sell
2,725
-6,741
-71% -$530K 0.17% 50
2019
Q4
$821K Buy
+9,466
New +$777K 0.68% 42

Other funds holding MRK

NWK Group's MRK Position: Q1 2026 in Review

NWK Group held its Merck (MRK) position steady in Q1 2026 at 2,000 shares worth $241K. The position accounts for 0.09% of the portfolio, ranked #44.

NWK Group first reported a position in MRK in Q4 2019 and has held it in 20 quarters since. The position peaked at $821K in Q4 2019. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • NWK Group held 2,000 shares of Merck worth $241K as of Q1 2026.
  • NWK Group left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.09% of NWK Group's portfolio in Q1 2026, its #44 holding.
  • NWK Group first reported a position in Merck in Q4 2019 and has held it in 20 quarters since.
  • NWK Group's Merck position peaked at $821K in Q4 2019.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on NWK Group's 13F filing for Q1 2026, filed 7 May 2026.